CAS: 211096-49-0 - N-(2-Bromophenyl)-N'-(4-cyano-1H-1,2,3-benzotriazol-7-yl)urea
Fórmula:C14H9BrN6O
- Sinónimos:
- Sb-265610
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Urea, N-(2-bromophenyl)-N'-(4-cyano-1H-benzotriazol-7-yl)- REF: AN-AG002L5GCAS: 211096-49-0 | ≥98%(HPLC) | A consultar | Lun 13 May 24 |
 | SB-265610 REF: TM-T16850CAS: 211096-49-0 | 97.67% | 55,00 €~1.612,00 € | Mar 21 May 24 |
 | SB-265610 REF: 3D-LIA09649CAS: 211096-49-0 | Min. 95% | A consultar | Mar 25 Jun 24 |
Urea, N-(2-bromophenyl)-N'-(4-cyano-1H-benzotriazol-7-yl)-
CAS:211096-49-0
Fórmula:
C14H9BrN6O
Pureza:
≥98%(HPLC)
Forma y color:
Solid
Peso molecular:
357.1649
Ref: AN-AG002L5G
| 1mg | 95,00 € | |
| 5mg | 175,00 € | |
| 10mg | 313,00 € | |
| 25mg | 588,00 € | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 13 de Mayo de 2024
SB-265610
CAS:211096-49-0
SB-265610 (GSK-CXCR2) is a nonpeptide and allosteric CXCR2 antagonist. SB-265610 blocks rat cytokine-induced neutrophil chemoattractant-1 …
Fórmula:
C14H9BrN6O
Pureza:
97.67%
Forma y color:
Solid
Peso molecular:
357.16
Ref: TM-T16850
| 1mg | 55,00 € | |
| 5mg | 118,00 € | |
| 10mg | 184,00 € | |
| 25mg | 370,00 € | |
| 50mg | 550,00 € | |
| 100mg | 786,00 € | |
| 500mg | 1.612,00 € | |
| 1ml*10 (DMSO) | 129,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Mayo de 2024
SB-265610
CAS:211096-49-0
SB-265610 is a selective inhibitor of the EGF receptor, which binds to the epidermal growth …
Fórmula:
C14H9BrN6O
Pureza:
Min. 95%
Peso molecular:
357.16 g/mol
Ref: 3D-LIA09649
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 25 de Junio de 2024
